PGT-A/PGT-M (Genetic Testing of Embryos) Treatment in New Delhi for Bangladesh

PGT-A/PGT-M (Genetic Testing of Embryos) in New Delhi for Bangladesh Patients

For many families in Bangladesh considering PGT-A/PGT-M, the journey often begins with complex questions about where to find advanced care. Uncertainty about the process, specialist availability, and international travel logistics can be a significant concern. Patients seek clarity and confidence in their choices.

New Delhi emerges as a preferred destination for such specialized treatments, drawing patients seeking high-quality reproductive healthcare. Its established medical infrastructure and the presence of leading fertility clinics offer a compelling reason for patients to look beyond their local options. The city provides a coordinated care environment.

Trust in New Delhi's medical fraternity is built on a foundation of experienced embryologists, genetic counselors, and reproductive endocrinologists. Hospitals within the city are equipped with state-of-the-art laboratories essential for advanced procedures like PGT-A/PGT-M, ensuring a reliable pathway for delicate genetic testing.

New Delhi offers comprehensive and advanced PGT-A/PGT-M solutions.

What is PGT-A/PGT-M (Genetic Testing of Embryos)?

PGT-A/PGT-M, or Preimplantation Genetic Testing, is an advanced technique used in conjunction with In Vitro Fertilization (IVF) to screen embryos for genetic abnormalities before implantation. PGT-A (aneuploidy) screens for chromosomal abnormalities, such as an extra or missing chromosome, which are a common cause of failed IVF cycles or miscarriage. PGT-M (monogenic disorders) specifically checks for single gene defects that cause inherited diseases like cystic fibrosis or sickle cell anemia. This testing helps identify healthy embryos, increasing the chances of a successful pregnancy and the birth of a healthy baby by reducing the risk of passing on specific genetic conditions.

Types of Preimplantation Genetic Testing

When is PGT-A/PGT-M Required?

• Advanced maternal age (typically over 35), increasing the risk of chromosomal abnormalities.
• History of recurrent miscarriages.
• Previous unsuccessful IVF cycles.
• Known carriers of a specific single gene disorder (PGT-M).
• One or both partners have a chromosomal structural rearrangement (PGT-SR).
• Desire to avoid termination of pregnancy due to a detected genetic condition.

Pre-Treatment Evaluation for PGT-A/PGT-M

• Genetic Counseling: Essential to assess family history, discuss genetic risks, and understand the implications of PGT-A/PGT-M.
• Fertility Assessment: Includes hormone tests (FSH, AMH, Estradiol) for females and semen analysis for males to evaluate reproductive health.
• Infectious Disease Screening: Blood tests for HIV, Hepatitis B and C, and other communicable diseases for both partners.
• Karyotyping: Chromosomal analysis for both partners, especially if PGT-M or PGT-SR is being considered.
• Mock Embryo Transfer: To assess the uterine cavity and optimize the actual embryo transfer procedure.
• Uterine Evaluation: Ultrasound or hysteroscopy to ensure the uterus is healthy for implantation.

How PGT-A/PGT-M is Performed

The procedure for PGT-A/PGT-M is integrated into an IVF cycle and involves several carefully managed steps.

Recovery Process After PGT-A/PGT-M

Recovery from PGT-A/PGT-M primarily involves the recovery from the initial IVF procedures. After egg retrieval, most women experience mild cramping and bloating for a few days. Following embryo transfer, a period of rest and avoiding strenuous activities is recommended. Patients can typically resume light daily activities within a day or two. The clinic will provide specific instructions for medication, usually progesterone supplements, to support the uterine lining. A pregnancy test is typically performed about two weeks after the embryo transfer. Follow-up consultations with the fertility specialist are important to monitor progress and discuss ongoing care.

Risks and Success Rates of PGT-A/PGT-M

• IVF-related risks: These include ovarian hyperstimulation syndrome (OHSS), mild discomfort from egg retrieval, or infection.
• Biopsy risks: While rare, there is a very small risk of damage to the embryo during the biopsy procedure.
• Diagnostic limitations: PGT-A/PGT-M is highly accurate but not 100% conclusive. There is a small possibility of false positives or false negatives, which may necessitate further prenatal testing.
• Mosaicism: Some embryos may have a mix of normal and abnormal cells (mosaic embryos), which can complicate decision-making regarding transfer.

The success rates of PGT-A/PGT-M are not measured by pregnancy rates directly, but by increasing the likelihood of a successful live birth per embryo transferred. By selecting genetically normal embryos, PGT-A can significantly improve implantation rates, reduce miscarriage rates, and decrease the time to achieving a successful pregnancy. PGT-M offers a high degree of confidence in preventing the transmission of specific genetic diseases. Individual outcomes vary based on factors such as maternal age, egg quality, overall health, the number of embryos available, and the specific genetic condition being screened. Patients should discuss their specific prognosis and expectations with their fertility specialist.

Cost of PGT-A/PGT-M in New Delhi

The cost of PGT-A/PGT-M in New Delhi can vary significantly based on several factors. These include the specific fertility clinic and its reputation, the experience of the specialists involved, the type and extent of genetic testing required (PGT-A, PGT-M, or both), the number of embryos biopsied, and any additional IVF procedures or medications needed. The technology used in the lab also plays a role in the overall expenditure.

For patients seeking PGT-A/PGT-M in New Delhi, the estimated cost typically ranges from INR 1,50,000 to INR 3,50,000, excluding the primary IVF cycle cost. This range generally covers the biopsy and genetic analysis per embryo batch.

Comprehensive Support Services for Your Treatment Journey

• Personalized treatment plan coordination from initial consultation to post-procedure care.
• Assistance with hospital appointments, specialist bookings, and second opinions.
• Language interpretation services to ensure clear communication with medical staff.
• Guidance on local accommodation and transport options within New Delhi.
• Dedicated patient support for any queries or concerns throughout your stay.

Key Documents Required for Your Medical Visit to New Delhi

• Valid passport and medical visa for entry into India.
• All previous medical records, including fertility test results, genetic reports, and treatment history.
• Referral letters from your primary healthcare provider, if applicable.
• Identity proof and proof of address from your home country.
• Any insurance documents or financial guarantee letters for treatment.

Steps to Prepare Before You Arrive for Treatment

• Complete all recommended pre-treatment evaluations and tests in your home country.
• Attend pre-travel genetic counseling sessions to clarify any concerns.
• Organize travel and accommodation well in advance.
• Inform your fertility specialist in New Delhi about your arrival schedule.
• Ensure all necessary medications you are currently taking are packed appropriately.

Essential Guidance for Aftercare and Recovery

• Follow all medication instructions precisely, including progesterone supplementation.
• Adhere to activity restrictions and avoid heavy lifting or strenuous exercise.
• Attend all scheduled follow-up appointments and blood tests.
• Maintain open communication with your New Delhi care team for any post-procedure symptoms.
• Plan for adequate rest and stress reduction during the two-week wait period.

Ready to Make Informed Decisions for Your Family?

Choosing PGT-A/PGT-M is a significant step toward a healthy future. New Delhi's advanced medical facilities are here to support you with expert care.